Dyadic International (NASDAQ:DYAI) Issues Earnings Results

Dyadic International (NASDAQ:DYAI) issued its quarterly earnings results on Wednesday. The biotechnology company reported ($0.05) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.01), Zacks reports. The firm had revenue of $0.82 million for the quarter, compared to analysts’ expectations of $1.60 million. Dyadic International had a negative net margin of 188.09% and a negative return on equity of 149.16%. During the same period in the prior year, the firm earned ($0.24) EPS.

Dyadic International Stock Down 3.6 %

Shares of NASDAQ:DYAI opened at $1.33 on Thursday. The company has a debt-to-equity ratio of 1.54, a current ratio of 5.15 and a quick ratio of 5.15. The business has a 50 day simple moving average of $1.48 and a two-hundred day simple moving average of $1.42. Dyadic International has a 1 year low of $0.93 and a 1 year high of $2.67. The firm has a market capitalization of $39.35 million, a PE ratio of -5.78 and a beta of 0.95.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Dyadic International stock. Bank of America Corp DE boosted its position in shares of Dyadic International, Inc. (NASDAQ:DYAI) by 16,146.7% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 27,132 shares of the biotechnology company’s stock after acquiring an additional 26,965 shares during the quarter. Bank of America Corp DE owned about 0.09% of Dyadic International worth $47,000 at the end of the most recent reporting period. 27.95% of the stock is currently owned by hedge funds and other institutional investors.

Dyadic International Company Profile

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.